Projects

RNDr. Rastislav Mucha, PhD.

National

Current
  • Molecular-biological analysis of the mechanism of ischemic tolerance in mitigating the consequences of stroke by conditioning
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • Neuroprotective and regenerative potential of post-traumatic cure targeted to Angiotensin II receptors
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Blood elements-derived secretome as a source of bioactive factors mediating the neuroprotection
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
Finished
  • Remote conditioning as a prevention and treatment of cerebral ischemia associated with hyper-inflammatory reaction (simulation of COVID-19)
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2024
  • The development of translationally relevant regenerative and reparative strategies after spinal cord trauma
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Mechanisms of glutamate metabolism as a tool of ischemic tolerance
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2023
  • The neuroprotection of synergic effect of the AT1 receptor blockade and AT2 receptor stimulation after traumatic spinal cord injury
    Program: SRDA
    Duration: 1. 7. 2019 – 30. 6. 2023
  • Identification of the protein markers activated in the process of induction of the ischemic tolerance
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2022
  • Identification of the protein markers activated in the process of induction of the ischemic tolerance
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2022
  • Neuroprotection in the process of ischemic tolerance acquisition from the perspective of rat brain pathways monitoring (proteomic MALDI-TOF/TOF study)
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • The role of glutamate transporters in blood cells in ischemic tolerance
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
Employees